Amryt Pharma plc (LON:AMYT – Get Free Report)’s stock price dropped 11.7% on Friday . The stock traded as low as GBX 143 ($1.80) and last traded at GBX 143 ($1.80). Approximately 90,726 shares were traded during trading, a decline of 81% from the average daily volume of 469,552 shares. The stock had previously closed at GBX 162 ($2.04).
Amryt Pharma Trading Down 11.7 %
The stock has a market capitalization of £457.11 million and a PE ratio of -4.33. The company has a current ratio of 1.80, a quick ratio of 1.14 and a debt-to-equity ratio of 66.05. The business’s 50-day moving average is GBX 143 and its two-hundred day moving average is GBX 143.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Recommended Stories
- Five stocks we like better than Amryt Pharma
- Expert Stock Trading Psychology Tips
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- ESG Stocks, What Investors Should Know
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Best Stocks Under $5.00
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
